Search
Menu
Home
HTB
2024
June
June 2024
Contents
Conference reports
CROI 2024 final reports: statins, doxy-PEP and TAF implant
Doxy-PEP studies at CROI 2024
HIV and statins: REPRIEVE studies at CROI 2024
Challenges with annual TAF implant
Paediatric care
CHIVA resources for children living with HIV
Guidelines
European guidelines on statins in people living with HIV (EACS 2024)
New CDC guidelines recommend selected use of doxy-PEP in the US (2024)
TB coinfection
An activist’s guide to rifapentine-based TB prevention (2024)
HIV prevention and transmission
Lenacapavir PrEP: 100% efficacy in cisgender women sets new challenges for global pricing and access
Cure-related research
Dynamics of the HIV reservoir after allogeneic haematopoietic stem-cell transplantation (HSCT)
Treatment advocacy
“Let’s talk about sex work”: A terminology statement and guide
HTB RSS
Early access
Closed clinics and limited ART in Zimbabwe, PEPFAR and UNAIDS news
4 May 2025
The RIO study: Q&A about controlling HIV with bNAbs
21 April 2025
Lenacapavir EAP in the UK closed to new referrals: NHS England and Gilead fail to agree a price after more than two years
20 April 2025
Viral failure on CAB/RPV-LA: overcoming drug resistance with second-generation INSTIs
13 April 2025
All early access reports
Current issues
May 2025
April 2025
March 2025
Back issues
Special report
Reduced dosing: a possible crisis response to ART stockouts and closed clinics
5 May 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate